Guangzhou LBP Medicine Science & Technology Co Ltd (688393) — Cash Flow-to-Debt Ratio
Guangzhou LBP Medicine Science & Technology Co Ltd (688393) has a Cash Flow-to-Debt Ratio of 0.26x as of September 2025, meaning its operating cash flow of CN¥29.17 Million could theoretically repay 0% of its total liabilities (CN¥113.31 Million) in one year. See Guangzhou LBP Medicine Science & Technol (688393) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Guangzhou LBP Medicine Science & Technology Co Ltd Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Guangzhou LBP Medicine Science & Technology Co Ltd across 12 annual periods. Also explore 688393 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Guangzhou LBP Medicine Science & Technology Co Ltd (2011–2024)
Year-by-year debt coverage analysis for Guangzhou LBP Medicine Science & Technology Co Ltd. For market capitalisation and broader financial context, see 688393 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.03x | CN¥3.54 Million | CN¥130.99 Million | ▼ -74.5% |
| 2023 | 0.11x | CN¥17.12 Million | CN¥161.63 Million | ▲ +85.8% |
| 2022 | 0.06x | CN¥9.72 Million | CN¥170.45 Million | ▼ -85.1% |
| 2021 | 0.38x | CN¥59.61 Million | CN¥155.96 Million | ▼ -47.9% |
| 2020 | 0.73x | CN¥91.43 Million | CN¥124.67 Million | ▼ -23.7% |
| 2019 | 0.96x | CN¥89.74 Million | CN¥93.33 Million | ▲ +28.4% |
| 2018 | 0.75x | CN¥65.35 Million | CN¥87.25 Million | ▼ -41.3% |
| 2017 | 1.28x | CN¥83.92 Million | CN¥65.78 Million | ▲ +6.1% |
| 2016 | 1.20x | CN¥43.37 Million | CN¥36.08 Million | ▲ +7369.7% |
| 2013 | -0.02x | CN¥-696.70K | CN¥42.13 Million | ▼ -106.4% |
| 2012 | 0.26x | CN¥4.84 Million | CN¥18.60 Million | ▲ +208.0% |
| 2011 | -0.24x | CN¥-15.24 Million | CN¥63.31 Million | — |